Stem Cells and Antibodies in Drug Discovery Europe 2018
-創藥領域中的幹細胞暨抗體學會歐洲大會2018年-
日期:2018年5月24-25日
地點:英國劍橋,Westminster College

主要演講者

Stefan Dubel

Stefan Dubel
Full Professor and Director, Technische Universitat Braunschweig

Gary Gintant

Gary Gintant
Research Fellow, Abbvie

David Hay

David Hay
Professor, University of Edinburgh

Paul French

Paul French
Professor, Department of Physics and Photonics Group, Imperial College London

Robert Williams

Robert Williams
Chief Drug Development Scientist, Cancer Research UK

Matthew Daniels

Matthew Daniels
Wellcome Trust Intermediate Clinical Fellow, Honorary Consultant Cardiologist, University of Oxford

Stephen Helliwell

Stephen Helliwell
Senior Investigator, Novartis Institutes for BioMedical Research

概要

Stem Cells in Drug Discovery 2018與Antibodies in Drug Discovery 2018將在英國劍橋舉辦。這些學會是Select Biosciences主辦的Innovations in Drug Discovery 2018中展開的一連串活動所構成。

與High-Content & Phenotypic Screening 2018同時舉行的本學會,將針對2018年以後影響創藥專案的新趨勢及新技術展開討論。

Stem Cells in Drug Discovery 2018:參加本學會能夠與運用iPS細胞群進行效能及毒性篩選的研究人員、統籌各種技術和手法開發的負責人談話並建立人脈。在會期中,預計針對創藥領域中可能大幅影響往後幹細胞運用的相關產業及法規面的動態進行討論。

Antibodies in Drug Discovery 2018:本學會的焦點為急遽成長的與生物製劑有關的抗體設計與改變的最新動態。本次主要探討的主題是,抗體工學領域的挑戰與方法、抗體開發新技術與事業的障礙、自體免疫疾病與傳染性疾病相關研究的最新動態等。本學會目標對象為抗體醫療創藥研究的專家,提供寶貴機會,可從在研究機構與製藥公司擔任指導角色的專家身上吸收知識,並與技術提供者的幹部建立人脈。

募集海報發表

參加會議的同時,可以用海報發表最新的研究成果。欲參加海報發表者,請在規定期限內繳交摘要。

海報發表摘要繳交期限:2018年5月14日

議程的主要議題

  • 3D 細胞模型
  • 對應新目標的抗體
  • 複合抗體藥物的設計(ADC)
  • 抗體篩選
  • 對應各種研究和治療用途的人源化單域抗體
  • 用於毒性測驗與篩選的iPS細胞生成之細胞
  • 單株抗體
  • 提升規模與品質管理
  • 篩選技術、器具、測試藥物
  • 在創藥與毒性篩選領域的幹細胞
  • 由生物製劑產生的離子通道目標化

募集贊助商與參展商

參展商與贊助商相關詳情請洽日商環球訊息有限公司台灣分公司。

目前已確定的演講者

Louise Affleck, UK Team Leader, Cisbio Bioassays
Ofer Binah, Professor, Department of Physiology, Biophysics and Systems Biology, Ruth & Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology
Hugh Byrne, Professor, Dublin Institute of Technology
Jacqueline Chuah, Lab Officer, Institute of Bioengineering and Nanotechnology, A*Star
Maciej Daniszewski, PhD Student, University of Melbourne
Nicholas Hannan, Assistant Professor, University of Nottingham
Ben Haworth, Cellular Imaging Application Specialist, GE Life Sciences
Peter Horvath, Finnish Distinguished Professor, Fellow FIMM Helsinki and Group Leader, Hungarian Academia of Sciences
Simon Hufton, Section Head Molecular Immunology, National Institute for Biological Standard and Control (NIBSC)
Hua Rong Lu, Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV
Peter O'Brien, Head of Clinical Pathology, University College Dublin
Alice Pebay, Associate Professor, Principal Research Fellow, University of Melbourne & Centre for Eye Research Australia
Sanjay Sinha, BHF Senior Research Fellow, University of Cambridge
Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
E. Sally Ward, Professor, Texas A&M University Health Science Center
Joanne Young, Senior Scientist, CYTOO SA


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Corporate Sponsors
Choose your language
Chinese
Japanese
Korean
English



免費電子郵件通知服務